Single-Pool Kt/V for β2-Microglobulin Highlights Differences Between Hemodiafiltration and Expanded Hemodialysis Therapies

Background: Elevated levels of Beta-2-microglobulin (β2m) in patients undergoing hemodialysis have been associated with increased mortality. Convective therapies such as hemodiafiltration (HDF) and expanded hemodialysis (HDx) enhance clearance of middle weight molecules (MWM), with β2m serving as a representative marker. This study aimed to evaluated and compare the efficacy of HDF and HDx in β2m removal, using a modified single-pool Kt/V (spKt/V b2m). Methods: From July 2024 to April 2025, monthly pre and post dialysis β2m and BUN levels were collected in our center. We analyzed 264 sessions from 36 patients (21 on HDF, and 15 on HDx). The spKt/V b2m was calculated using the Casino et al formula: spKt/V b2m = 6.12DW/W [1−ln (Ct / C0) / ln (1 + 6.12DW/W)] where DW/W is the net ultrafiltration volume relative to post-dialysis weight, C0 and Ct are pre and post dialysis β2m concentrations. This derives from Leypoldt’s clearance model: K b2m = Qf [1−ln (Ct / C0) / ln (1 + Qf * Td / V b2m)] Qf: net fluid removal rate (mL/min); Td session duration (min); V β2m: distribution volume for β2m, assumed to be one-third of urea distribution volume (Vurea = 49% of body weight). The equilibrated Kt/V (eKt/V b2m) was calculated as: eKt/V b2m = spKt/V b2m * Td / (Td + 110) Results: All dialysis sessions lasted 240 minutes. The mean Qb was 364 ±18 mL/min, Qd 482 ± 51 ml/min, and net weight loss 2.1 ± 0.8 kg. In HDF mean convective volume was 27.2 ± 3.2 L/session. HDF demonstrated significantly higher β2m clearance than HDx: K b2m 125.4 ± 20.6 vs 115.0 ± 30.3 ml/min (p =0.001), spKt/V b2m 3.2 ± 0.3 vs 2.7 ± 0.2 (p <0.001), and eKt/V b2m 2.2 ± 0.2 vs 1.8 ± 0.1 (p <0.001) (Fig. 1). Conclusion: HDF demonstrated superior β2m removal compared to HDx, supported by higher of K b2m, spKt/V b2m and eKt/V b2m. These findings reinforce the advantage of convective therapies for MWM clearance in chronic hemodialysis patients.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.20251v3eq3xv
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Single-Pool Kt/V for β2-Microglobulin Highlights Differences Between Hemodiafiltration and Expanded Hemodialysis Therapies

Olynka Vega‐Vega, Noemí Del Toro-Cisneros, Alejandro Quiñonez-Flores, Erick Yasar Zuñiga Gonzalez et al.
Journal of the American Society of Nephrology
Dialysis and Renal Disease Management
article

Single-Pool Kt/V for β2-Microglobulin Highlights Differences Between Hemodiafiltration and Expanded Hemodialysis Therapies

Olynka Vega‐Vega, Noemí Del Toro-Cisneros, Alejandro Quiñonez-Flores, Erick Yasar Zuñiga Gonzalez, Rodolfo Rincón-Pedrero
article en

Abstract

Background: Elevated levels of Beta-2-microglobulin (β2m) in patients undergoing hemodialysis have been associated with increased mortality. Convective therapies such as hemodiafiltration (HDF) and expanded hemodialysis (HDx) enhance clearance of middle weight molecules (MWM), with β2m serving as a representative marker. This study aimed to evaluated and compare the efficacy of HDF and HDx in β2m removal, using a modified single-pool Kt/V (spKt/V b2m). Methods: From July 2024 to April 2025, monthly pre and post dialysis β2m and BUN levels were collected in our center. We analyzed 264 sessions from 36 patients (21 on HDF, and 15 on HDx). The spKt/V b2m was calculated using the Casino et al formula: spKt/V b2m = 6.12DW/W [1−ln (Ct / C0) / ln (1 + 6.12DW/W)] where DW/W is the net ultrafiltration volume relative to post-dialysis weight, C0 and Ct are pre and post dialysis β2m concentrations. This derives from Leypoldt’s clearance model: K b2m = Qf [1−ln (Ct / C0) / ln (1 + Qf * Td / V b2m)] Qf: net fluid removal rate (mL/min); Td session duration (min); V β2m: distribution volume for β2m, assumed to be one-third of urea distribution volume (Vurea = 49% of body weight). The equilibrated Kt/V (eKt/V b2m) was calculated as: eKt/V b2m = spKt/V b2m * Td / (Td + 110) Results: All dialysis sessions lasted 240 minutes. The mean Qb was 364 ±18 mL/min, Qd 482 ± 51 ml/min, and net weight loss 2.1 ± 0.8 kg. In HDF mean convective volume was 27.2 ± 3.2 L/session. HDF demonstrated significantly higher β2m clearance than HDx: K b2m 125.4 ± 20.6 vs 115.0 ± 30.3 ml/min (p =0.001), spKt/V b2m 3.2 ± 0.3 vs 2.7 ± 0.2 (p <0.001), and eKt/V b2m 2.2 ± 0.2 vs 1.8 ± 0.1 (p <0.001) (Fig. 1). Conclusion: HDF demonstrated superior β2m removal compared to HDx, supported by higher of K b2m, spKt/V b2m and eKt/V b2m. These findings reinforce the advantage of convective therapies for MWM clearance in chronic hemodialysis patients.

Journal of the American Society of NephrologyVol. 36(10S)
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
Openalex Percentile: Top 65%
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.